Breaking News Instant updates and real-time market news.

GILD

Gilead

$69.70 /

+2.72 (+4.06%)

09:24
02/24/20
02/24
09:24
02/24/20
09:24

Gilead jumps as WHO touts potential of remdesivir for coronavirus

Shares of Gilead are up sharply in pre-market trading after an assistant director-general at the World Health Organization touted the potential of the company's drug as a tool in combating the novel coronavirus outbreak that has plagued China and his begun to spread more quickly in other countries. Previously, Reuters reported that a study showed that an experimental Gilead antiviral drug prevented disease and reduced the severity of symptoms in monkeys infected with MERS, an infection closely related to the coronavirus. Over the weekend, Bruce Aylward, an assistant director-general at the World Health Organization, said at a briefing in Beijing that remdesivir is the "one drug right now that we think may have efficacy" in treating the new coronavirus, according to Bloomberg. In pre-market trading, Gilead shares are up $5.45, or 7.8%, to $75.15. Reference Link

  • 02

    Mar

  • 10

    Aug

GILD Gilead
$69.70 /

+2.72 (+4.06%)

02/24/20 Stifel
Galapagos price target raised to $298 from $188 at Stifel
02/06/20 Bernstein
Gilead downgraded to Market Perform from Outperform at Bernstein
02/05/20
Fly Intel: Top five analyst downgrades
02/05/20 Raymond James
Gilead downgraded on 'flat but sturdy' outlook at Raymond James

TODAY'S FREE FLY STORIES

Recommendations
Netflix retakes lead in teen video share, Piper Sandler survey shows » 05:15
04/08/20
04/08
05:15
04/08/20
05:15
NFLX

Netflix

$372.28 /

-7.64 (-2.01%)

, GOOG

Alphabet

$1,187.12 /

+2.61 (+0.22%)

, GOOGL

Alphabet Class A

$1,180.70 /

+0.49 (+0.04%)

, DIS

Disney

$101.10 /

+1.82 (+1.83%)

, AAPL

Apple

$259.50 /

-2.88 (-1.10%)

Piper Sandler surveyed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Recommendations
Iqvia price target lowered to $115 from $163 at Piper Sandler » 05:10
04/08/20
04/08
05:10
04/08/20
05:10
IQV

Iqvia

$119.68 /

+2.47 (+2.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Initiation
Federal Realty initiated with a Buy at Odeon Capital » 05:09
04/08/20
04/08
05:09
04/08/20
05:09
FRT

Federal Realty

$75.39 /

+2.48 (+3.40%)

Odeon Capital initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Mueller Water upgraded to Neutral from Sell at Goldman Sachs » 05:08
04/08/20
04/08
05:08
04/08/20
05:08
MWA

Mueller Water

$8.14 /

+0.105 (+1.31%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Xylem downgraded to Sell from Neutral at Goldman Sachs » 05:07
04/08/20
04/08
05:07
04/08/20
05:07
XYL

Xylem

$66.35 /

+1.16 (+1.78%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Evoqua Water upgraded to Buy from Neutral at Goldman Sachs » 05:06
04/08/20
04/08
05:06
04/08/20
05:06
AQUA

Evoqua Water

$13.20 /

+1.02 (+8.37%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
CSX upgraded to Buy from Neutral at Goldman Sachs » 05:03
04/08/20
04/08
05:03
04/08/20
05:03
CSX

CSX

$61.10 /

-0.26 (-0.42%)

Goldman Sachs analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Asos upgraded to Buy from Hold at Jefferies » 05:00
04/08/20
04/08
05:00
04/08/20
05:00
ASOMY

Asos

$0.00 /

+ (+0.00%)

Jefferies analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Stewart upgraded to Market Perform from Underperform at Keefe Bruyette » 04:58
04/08/20
04/08
04:58
04/08/20
04:58
STC

Stewart

$25.46 /

+0.48 (+1.92%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
First American upgraded to Outperform from Market Perform at Keefe Bruyette » 04:58
04/08/20
04/08
04:58
04/08/20
04:58
FAF

First American

$42.25 /

+0.245 (+0.58%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Upgrade
Fidelity National upgraded to Outperform from Market Perform at Keefe Bruyette » 04:57
04/08/20
04/08
04:57
04/08/20
04:57
FNF

Fidelity National

$25.72 /

+1.42 (+5.84%)

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
TD Ameritrade downgraded to Market Perform from Outperform at Keefe Bruyette » 04:56
04/08/20
04/08
04:56
04/08/20
04:56
AMTD

TD Ameritrade

/

+

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Charles Schwab downgraded to Market Perform from Outperform at Keefe Bruyette » 04:55
04/08/20
04/08
04:55
04/08/20
04:55
SCHW

Charles Schwab

/

+

Keefe Bruyette analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
UBS financial analyst to hold an analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Financial Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Kinsale Capital Group participates in a conference call with JMP Securities » 04:55
04/08/20
04/08
04:55
04/08/20
04:55
KNSL

Kinsale Capital Group

$107.64 /

+0.82 (+0.77%)

Conference call with CEO…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Jefferies semiconductors analyst to hold an analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Semiconductors Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley oil/energy analysts to hold analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Global Oil Strategist…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
UBS leisure, gaming & lodging analyst to hold analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Leisure, Gaming &…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Conference/Events
Morgan Stanley healthcare analysts to hold an analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Healthcare Analysts…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Lowe's participates in a conference call with Credit Suisse » 04:55
04/08/20
04/08
04:55
04/08/20
04:55
LOW

Lowe's

$90.93 /

+2.22 (+2.50%)

Consumer Services Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Piper Sandler financial services analysts to hold analyst/industry call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55
AXP

American Express

$87.53 /

+3.74 (+4.46%)

, BAC

Bank of America

$22.14 /

+0.8 (+3.75%)

, ENV

Envestnet

$50.27 /

+1.4 (+2.86%)

, JPM

JPMorgan

$90.46 /

+1.37 (+1.54%)

, MA

MasterCard

$258.99 /

-6.17 (-2.33%)

, MSFT

Microsoft

$163.53 /

-1.74 (-1.05%)

, V

Visa

$168.47 /

-0.84 (-0.50%)

Financial Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Conference/Events
Morgan Stanley consumer goods analysts to hold analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Consumer Discretionary…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Credit Suisse financial service analyst to hold analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Financial Services…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
BTIG software analysts to hold analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55

Software Analysts discuss…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Conference/Events
Deutsche Bank software analyst to hold an analyst/industry conference call » 04:55
04/08/20
04/08
04:55
04/08/20
04:55
DXC

DXC Technology

$13.92 /

+0.39 (+2.88%)

Software Analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.